Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6879 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
1987-07-15^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1991-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e1c5b9a976fd0e0a2bd2b067094e3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_039c9704f2b6f8c960653f8c7e4613a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05889d657a285d444e6e18f1f645c32a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63be6f605b5d6b912a0491f2f15e56f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f60ee95bb0658aec4b35ddeb2827019 |
publicationDate |
1991-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5053226-A |
titleOfInvention |
Monoclonal antibodies binding platinum complexes |
abstract |
The present invention relates to monoclonal antibodies specifically binding platinum (II) complex. The monoclonal antibodies of the present invention are characteristically produced by antibody-producing cell lines such as hybridomas. These cell lines may result, for example, from fusion of a neoplastic cell with an antibody-producing animal cell obtained from an animal immunized against a platinum (II) complex. The cellular fusion products include cell lines forming monoclonal antibody specifically binding platinum (II) complex in competition with an antibody produced by: hybridoma strain 1C1H2A5, deposited with the American Type Culture Collection, Rockville, MD on May 1, 1987 and having ATCC accession number HB 9411; strain 3A2A1; strain 1A6A2; strain 3A6B1 or strain 1B1. The cell lines of the present invention are preferably continuous murine hybridoma cell lines which secrete recoverable quantities of monoclonal antibody, particularly a monoclonal antibody which is of an IgG or IgM isotype. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2266607-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5476939-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5985566-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5654160-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5663301-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5670627-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5670645-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5681960-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2289549-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5683907-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5631172-A |
priorityDate |
1987-07-15^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |